D. E. Shaw & Co., Inc. - AMERICAN RENAL ASSOCIATES HO ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of AMERICAN RENAL ASSOCIATES HO
ValueSharesWeighting
Q4 2020$537,000
+0.2%
46,941
-39.6%
0.00%
-100.0%
Q3 2020$536,000
-23.1%
77,665
-27.3%
0.00%0.0%
Q2 2020$697,000
+17.1%
106,856
+18.8%
0.00%0.0%
Q1 2020$595,000
-33.3%
89,957
+4.6%
0.00%0.0%
Q4 2019$892,000
+61.9%
86,029
-1.3%
0.00%0.0%
Q3 2019$551,00087,1540.00%
Other shareholders
AMERICAN RENAL ASSOCIATES HO shareholders Q3 2023
NameSharesValueWeighting ↓
Centerbridge Partners 17,615,836$306,516,00034.76%
Whitegate Investment Counselors, Inc. 654,284$11,385,0002.38%
Van Berkom & Associates Inc. 2,558,888$44,525,0001.45%
AMI ASSET MANAGEMENT CORP 684,396$11,908,0000.82%
Endurant Capital Management LP 89,129$1,551,0000.47%
Alambic Investment Management, L.P. 81,350$1,415,0000.17%
SHINE INVESTMENT ADVISORY SERVICES INC 17,596$306,0000.15%
TimesSquare Capital Management, LLC 1,053,100$18,324,0000.12%
CORNERCAP INVESTMENT COUNSEL INC 48,160$838,0000.12%
ALTRINSIC GLOBAL ADVISORS LLC 130,000$2,262,0000.09%
View complete list of AMERICAN RENAL ASSOCIATES HO shareholders